

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.61930077 |
| 2 | * locomotory exploration behavior (GO:0035641) | 5.53454451 |
| 3 | central nervous system myelination (GO:0022010) | 5.38588746 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 5.38588746 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.23796612 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.18560335 |
| 7 | vocalization behavior (GO:0071625) | 5.14250205 |
| 8 | * neuron cell-cell adhesion (GO:0007158) | 5.11867841 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.75730027 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.73082551 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.72519775 |
| 12 | L-amino acid import (GO:0043092) | 4.72066464 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.60937855 |
| 14 | protein localization to synapse (GO:0035418) | 4.59856823 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54679926 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.50584375 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.46573342 |
| 18 | amino acid import (GO:0043090) | 4.45663662 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 4.36826685 |
| 20 | postsynaptic membrane organization (GO:0001941) | 4.36374691 |
| 21 | potassium ion import (GO:0010107) | 4.35287431 |
| 22 | * exploration behavior (GO:0035640) | 4.25600311 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.21625804 |
| 24 | glutamate secretion (GO:0014047) | 4.19821846 |
| 25 | potassium ion homeostasis (GO:0055075) | 4.19751740 |
| 26 | transmission of nerve impulse (GO:0019226) | 4.18141346 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 4.17229250 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.13330834 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.05847186 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 4.02770483 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.96044016 |
| 32 | regulation of synapse maturation (GO:0090128) | 3.96023522 |
| 33 | neurotransmitter uptake (GO:0001504) | 3.92849774 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.91288398 |
| 35 | presynaptic membrane organization (GO:0097090) | 3.88741878 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.87872851 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.86515864 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.77826738 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.77524354 |
| 40 | neuronal action potential propagation (GO:0019227) | 3.77113056 |
| 41 | neuron recognition (GO:0008038) | 3.75017947 |
| 42 | long-term memory (GO:0007616) | 3.71421637 |
| 43 | dermatan sulfate metabolic process (GO:0030205) | 3.68933715 |
| 44 | neurotransmitter secretion (GO:0007269) | 3.68353231 |
| 45 | * long-term synaptic potentiation (GO:0060291) | 3.62362322 |
| 46 | startle response (GO:0001964) | 3.58949397 |
| 47 | dendrite morphogenesis (GO:0048813) | 3.57754139 |
| 48 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.56574033 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.55478935 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.48010966 |
| 51 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.47912204 |
| 52 | innervation (GO:0060384) | 3.46180638 |
| 53 | astrocyte differentiation (GO:0048708) | 3.44894274 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 3.41728206 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.41167294 |
| 56 | membrane assembly (GO:0071709) | 3.40141118 |
| 57 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39855681 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.39594824 |
| 59 | photoreceptor cell differentiation (GO:0046530) | 3.39519431 |
| 60 | eye photoreceptor cell differentiation (GO:0001754) | 3.39519431 |
| 61 | membrane depolarization during action potential (GO:0086010) | 3.38409014 |
| 62 | regulation of postsynaptic membrane potential (GO:0060078) | 3.38403674 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.36497353 |
| 64 | axonal fasciculation (GO:0007413) | 3.36019343 |
| 65 | neuronal ion channel clustering (GO:0045161) | 3.34326016 |
| 66 | cellular sodium ion homeostasis (GO:0006883) | 3.33867607 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30465571 |
| 68 | auditory behavior (GO:0031223) | 3.30246143 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28328827 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.27657308 |
| 71 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.26379989 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26118258 |
| 73 | * regulation of synaptic plasticity (GO:0048167) | 3.25731335 |
| 74 | response to auditory stimulus (GO:0010996) | 3.25392960 |
| 75 | synapse assembly (GO:0007416) | 3.23867094 |
| 76 | cerebellar granule cell differentiation (GO:0021707) | 3.20874197 |
| 77 | neurotransmitter transport (GO:0006836) | 3.14318784 |
| 78 | oligodendrocyte differentiation (GO:0048709) | 3.13856599 |
| 79 | righting reflex (GO:0060013) | 3.12032407 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.10223712 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09646465 |
| 82 | proline transport (GO:0015824) | 3.07452070 |
| 83 | regulation of neurotransmitter secretion (GO:0046928) | 3.07124698 |
| 84 | positive regulation of synapse maturation (GO:0090129) | 2.99436239 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 2.98688461 |
| 86 | dendritic spine organization (GO:0097061) | 2.98355537 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.96365210 |
| 88 | regulation of neurotransmitter uptake (GO:0051580) | 2.95004226 |
| 89 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94578494 |
| 90 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.93575405 |
| 91 | cell communication by electrical coupling (GO:0010644) | 2.93083454 |
| 92 | regulation of respiratory system process (GO:0044065) | 2.92394210 |
| 93 | membrane depolarization (GO:0051899) | 2.91032240 |
| 94 | regulation of female receptivity (GO:0045924) | 2.91020411 |
| 95 | * synapse organization (GO:0050808) | 2.90933796 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.90178394 |
| 97 | * learning (GO:0007612) | 2.89612309 |
| 98 | C4-dicarboxylate transport (GO:0015740) | 2.88502212 |
| 99 | myelination (GO:0042552) | 2.88450929 |
| 100 | peripheral nervous system development (GO:0007422) | 2.88313726 |
| 101 | positive regulation of dendritic spine development (GO:0060999) | 2.88241561 |
| 102 | * neuromuscular process controlling balance (GO:0050885) | 2.88191958 |
| 103 | * positive regulation of synaptic transmission (GO:0050806) | 2.87340637 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86527370 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.86161162 |
| 106 | chondroitin sulfate catabolic process (GO:0030207) | 2.85520147 |
| 107 | prepulse inhibition (GO:0060134) | 2.83766963 |
| 108 | positive regulation of synapse assembly (GO:0051965) | 2.83465780 |
| 109 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.82411185 |
| 110 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81077894 |
| 111 | mechanosensory behavior (GO:0007638) | 2.79965992 |
| 112 | regulation of neurotransmitter levels (GO:0001505) | 2.79592900 |
| 113 | dermatan sulfate biosynthetic process (GO:0030208) | 2.79484024 |
| 114 | * regulation of synaptic transmission (GO:0050804) | 2.78579987 |
| 115 | acidic amino acid transport (GO:0015800) | 2.78496725 |
| 116 | regulation of vesicle fusion (GO:0031338) | 2.78474647 |
| 117 | adult walking behavior (GO:0007628) | 2.77621792 |
| 118 | sodium ion export (GO:0071436) | 2.77482596 |
| 119 | detection of calcium ion (GO:0005513) | 2.76189120 |
| 120 | activation of protein kinase A activity (GO:0034199) | 2.75235782 |
| 121 | chemosensory behavior (GO:0007635) | 2.74893951 |
| 122 | L-glutamate transport (GO:0015813) | 2.74404376 |
| 123 | glycine transport (GO:0015816) | 2.73138734 |
| 124 | synaptic transmission (GO:0007268) | 2.71408700 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.68252103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.20014293 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.81350657 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02768958 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96403550 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92673343 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56520550 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56520550 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52379873 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49718611 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.49035666 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47717744 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47688623 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43225837 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40698328 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39258702 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38697169 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36486617 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30451526 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17273560 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16130604 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12498571 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10626718 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07510085 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94759428 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88666911 |
| 26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88360900 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83898798 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82234332 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.79618374 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75903966 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75270354 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66656327 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59513723 |
| 34 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59086269 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57687408 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56761602 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51882218 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49539212 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49054967 |
| 40 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46916881 |
| 41 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44760843 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42817697 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42410749 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41583562 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40746262 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40694010 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.40415442 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39622914 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39079121 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38937910 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34798554 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33591471 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30172893 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27162849 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26950414 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26375640 |
| 57 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25342005 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22796853 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22339825 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.22220448 |
| 61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20336134 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17517713 |
| 63 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.16840753 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14746006 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14550844 |
| 66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14413585 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14237320 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13938352 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13577187 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13525812 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13346776 |
| 72 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11058521 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11058521 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10921204 |
| 75 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10297696 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09645317 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08576801 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08569195 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08432988 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07449627 |
| 81 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07316851 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07273342 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06450561 |
| 84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06388210 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06310594 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06251006 |
| 87 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04406740 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03426766 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02956602 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01596799 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01401285 |
| 92 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00832304 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99315851 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98854533 |
| 95 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98708907 |
| 96 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98281552 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96593241 |
| 98 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96415578 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96176036 |
| 100 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95373076 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95023278 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93822059 |
| 103 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.93300177 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92487665 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92245669 |
| 106 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90529878 |
| 107 | JUN_21703547_ChIP-Seq_K562_Human | 0.90353390 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89985438 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88960038 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88621915 |
| 111 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87557868 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87525710 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87502006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.61565505 |
| 2 | MP0003880_abnormal_central_pattern | 4.88004049 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.82681423 |
| 4 | MP0004270_analgesia | 3.38176120 |
| 5 | MP0009745_abnormal_behavioral_response | 3.18908749 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.11744748 |
| 7 | MP0002064_seizures | 3.05498028 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.01828011 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.75062294 |
| 10 | MP0001486_abnormal_startle_reflex | 2.75021480 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.70979120 |
| 12 | MP0009046_muscle_twitch | 2.69485286 |
| 13 | * MP0002272_abnormal_nervous_system | 2.52931369 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.49482574 |
| 15 | MP0002736_abnormal_nociception_after | 2.19204412 |
| 16 | MP0001984_abnormal_olfaction | 2.08359830 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.04683518 |
| 18 | MP0002822_catalepsy | 2.04603468 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.01592870 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.01488176 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.99266079 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.99074037 |
| 23 | MP0004858_abnormal_nervous_system | 1.97470960 |
| 24 | MP0000778_abnormal_nervous_system | 1.95914685 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.93731102 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.91043929 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.89184910 |
| 28 | MP0008569_lethality_at_weaning | 1.83586043 |
| 29 | MP0002733_abnormal_thermal_nociception | 1.83222110 |
| 30 | MP0004742_abnormal_vestibular_system | 1.80674235 |
| 31 | MP0001970_abnormal_pain_threshold | 1.80572821 |
| 32 | MP0002184_abnormal_innervation | 1.76086948 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.75967767 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.65285043 |
| 35 | MP0004885_abnormal_endolymph | 1.65008012 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.63336188 |
| 37 | MP0003329_amyloid_beta_deposits | 1.58963803 |
| 38 | MP0000955_abnormal_spinal_cord | 1.57303438 |
| 39 | MP0000920_abnormal_myelination | 1.54867022 |
| 40 | MP0001529_abnormal_vocalization | 1.52020539 |
| 41 | MP0003690_abnormal_glial_cell | 1.51518292 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.50637144 |
| 43 | * MP0002882_abnormal_neuron_morphology | 1.47427202 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.47340640 |
| 45 | MP0004924_abnormal_behavior | 1.47340640 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.44437253 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.39298419 |
| 48 | MP0003787_abnormal_imprinting | 1.38315652 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.38266069 |
| 50 | MP0004142_abnormal_muscle_tone | 1.37202334 |
| 51 | MP0003879_abnormal_hair_cell | 1.36779148 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.35017656 |
| 53 | MP0005171_absent_coat_pigmentation | 1.32290222 |
| 54 | MP0003633_abnormal_nervous_system | 1.31367254 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.26567587 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.26329806 |
| 57 | MP0003634_abnormal_glial_cell | 1.26252715 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.20270323 |
| 59 | MP0001905_abnormal_dopamine_level | 1.16008515 |
| 60 | MP0002229_neurodegeneration | 1.12761444 |
| 61 | MP0000631_abnormal_neuroendocrine_gland | 1.09984324 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.09174878 |
| 63 | MP0002090_abnormal_vision | 1.06246255 |
| 64 | MP0005409_darkened_coat_color | 1.06171747 |
| 65 | * MP0002152_abnormal_brain_morphology | 1.05735919 |
| 66 | MP0001188_hyperpigmentation | 1.05434656 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.04591438 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.02922787 |
| 69 | * MP0003631_nervous_system_phenotype | 1.02701107 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 1.00294543 |
| 71 | MP0003122_maternal_imprinting | 0.99016076 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 0.96740370 |
| 73 | MP0001177_atelectasis | 0.96239477 |
| 74 | MP0003283_abnormal_digestive_organ | 0.94184179 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.93336701 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.92459085 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.92314966 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.91216467 |
| 79 | MP0001299_abnormal_eye_distance/ | 0.88032129 |
| 80 | MP0005253_abnormal_eye_physiology | 0.85757025 |
| 81 | MP0003136_yellow_coat_color | 0.77895661 |
| 82 | MP0004130_abnormal_muscle_cell | 0.75796937 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.74636401 |
| 84 | MP0004147_increased_porphyrin_level | 0.74370516 |
| 85 | * MP0003632_abnormal_nervous_system | 0.73016468 |
| 86 | MP0005535_abnormal_body_temperature | 0.71411987 |
| 87 | MP0004043_abnormal_pH_regulation | 0.71118342 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.70918220 |
| 89 | MP0000569_abnormal_digit_pigmentation | 0.70041656 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.69843646 |
| 91 | MP0005499_abnormal_olfactory_system | 0.69843646 |
| 92 | MP0004085_abnormal_heartbeat | 0.69637639 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.67372572 |
| 94 | MP0000579_abnormal_nail_morphology | 0.67308938 |
| 95 | MP0008874_decreased_physiological_sensi | 0.64182052 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.63899697 |
| 97 | MP0000604_amyloidosis | 0.63135949 |
| 98 | MP0000026_abnormal_inner_ear | 0.62399718 |
| 99 | MP0008872_abnormal_physiological_respon | 0.62098287 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.61807072 |
| 101 | MP0003868_abnormal_feces_composition | 0.61757901 |
| 102 | MP0001943_abnormal_respiration | 0.60316415 |
| 103 | MP0010769_abnormal_survival | 0.60254356 |
| 104 | MP0010770_preweaning_lethality | 0.59651117 |
| 105 | MP0002082_postnatal_lethality | 0.59651117 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.59125574 |
| 107 | MP0003861_abnormal_nervous_system | 0.58534041 |
| 108 | MP0005195_abnormal_posterior_eye | 0.58102261 |
| 109 | MP0010768_mortality/aging | 0.56823279 |
| 110 | MP0003075_altered_response_to | 0.56245402 |
| 111 | MP0000462_abnormal_digestive_system | 0.54178504 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.53171034 |
| 113 | MP0005670_abnormal_white_adipose | 0.50941751 |
| 114 | MP0003956_abnormal_body_size | 0.49896792 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.48455608 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.41831627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.77177061 |
| 2 | Myokymia (HP:0002411) | 5.47638987 |
| 3 | Focal seizures (HP:0007359) | 5.07328276 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.43234133 |
| 5 | Atonic seizures (HP:0010819) | 4.43048760 |
| 6 | Visual hallucinations (HP:0002367) | 4.33673854 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.29763313 |
| 8 | Febrile seizures (HP:0002373) | 4.24732049 |
| 9 | Action tremor (HP:0002345) | 3.72557309 |
| 10 | Absence seizures (HP:0002121) | 3.66374187 |
| 11 | Septo-optic dysplasia (HP:0100842) | 3.63163538 |
| 12 | Hyperventilation (HP:0002883) | 3.59356103 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.47956698 |
| 14 | Dysdiadochokinesis (HP:0002075) | 3.47831022 |
| 15 | Broad-based gait (HP:0002136) | 3.46514375 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.45256232 |
| 17 | Dialeptic seizures (HP:0011146) | 3.45160938 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.31575334 |
| 19 | Absent speech (HP:0001344) | 3.11553244 |
| 20 | Ankle clonus (HP:0011448) | 3.06926133 |
| 21 | Dysmetria (HP:0001310) | 3.05610809 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.02214870 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.98398811 |
| 24 | Postural instability (HP:0002172) | 2.97650137 |
| 25 | Truncal ataxia (HP:0002078) | 2.91862767 |
| 26 | Depression (HP:0000716) | 2.91840409 |
| 27 | Intention tremor (HP:0002080) | 2.90511951 |
| 28 | Limb dystonia (HP:0002451) | 2.90200180 |
| 29 | Blue irides (HP:0000635) | 2.84876103 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.84307280 |
| 31 | Hemiparesis (HP:0001269) | 2.83754957 |
| 32 | Scanning speech (HP:0002168) | 2.80652291 |
| 33 | Excessive salivation (HP:0003781) | 2.78871694 |
| 34 | Drooling (HP:0002307) | 2.78871694 |
| 35 | Morphological abnormality of the inner ear (HP:0011390) | 2.78505052 |
| 36 | Anxiety (HP:0000739) | 2.74701485 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.73931163 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.73000866 |
| 39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.70535902 |
| 40 | Papilledema (HP:0001085) | 2.69522435 |
| 41 | Fetal akinesia sequence (HP:0001989) | 2.68996975 |
| 42 | Poor eye contact (HP:0000817) | 2.66054954 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 2.65301492 |
| 44 | Mutism (HP:0002300) | 2.59662460 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.59249740 |
| 46 | Optic nerve hypoplasia (HP:0000609) | 2.57263409 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54754804 |
| 48 | Spastic gait (HP:0002064) | 2.54293257 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.50655379 |
| 50 | Abnormal social behavior (HP:0012433) | 2.49550521 |
| 51 | Impaired social interactions (HP:0000735) | 2.49550521 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.43156140 |
| 53 | Peripheral hypomyelination (HP:0007182) | 2.42965252 |
| 54 | Split foot (HP:0001839) | 2.41714322 |
| 55 | Status epilepticus (HP:0002133) | 2.39593312 |
| 56 | Oligodactyly (hands) (HP:0001180) | 2.39069755 |
| 57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.38557089 |
| 58 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.38557089 |
| 59 | Genetic anticipation (HP:0003743) | 2.35928454 |
| 60 | Alacrima (HP:0000522) | 2.33926196 |
| 61 | Amblyopia (HP:0000646) | 2.32771541 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.31930082 |
| 63 | Metabolic alkalosis (HP:0200114) | 2.31103686 |
| 64 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26000061 |
| 65 | Stereotypic behavior (HP:0000733) | 2.23176302 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.22206285 |
| 67 | Diplopia (HP:0000651) | 2.22206285 |
| 68 | Cerebral hypomyelination (HP:0006808) | 2.19789851 |
| 69 | Increased circulating renin level (HP:0000848) | 2.19662105 |
| 70 | Hemiplegia (HP:0002301) | 2.18969744 |
| 71 | Lower limb muscle weakness (HP:0007340) | 2.18275516 |
| 72 | Abnormality of cochlea (HP:0000375) | 2.17922304 |
| 73 | Bundle branch block (HP:0011710) | 2.17381191 |
| 74 | Megalencephaly (HP:0001355) | 2.17367587 |
| 75 | Sleep apnea (HP:0010535) | 2.16440615 |
| 76 | Abnormality of the sella turcica (HP:0002679) | 2.14914290 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.13882216 |
| 78 | Torticollis (HP:0000473) | 2.13598881 |
| 79 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.13015567 |
| 80 | Retinal dysplasia (HP:0007973) | 2.12671091 |
| 81 | Akinesia (HP:0002304) | 2.10857089 |
| 82 | Pheochromocytoma (HP:0002666) | 2.08439858 |
| 83 | Bradykinesia (HP:0002067) | 2.06373501 |
| 84 | Tetraplegia (HP:0002445) | 2.06002503 |
| 85 | Polyphagia (HP:0002591) | 2.04836438 |
| 86 | Widely spaced teeth (HP:0000687) | 2.03550583 |
| 87 | Hypokalemic alkalosis (HP:0001949) | 2.02996154 |
| 88 | Agitation (HP:0000713) | 2.02335393 |
| 89 | Urinary urgency (HP:0000012) | 1.95765866 |
| 90 | Gait imbalance (HP:0002141) | 1.94585390 |
| 91 | Progressive inability to walk (HP:0002505) | 1.93541492 |
| 92 | Spastic tetraparesis (HP:0001285) | 1.93257433 |
| 93 | Abnormality of the septum pellucidum (HP:0007375) | 1.93078787 |
| 94 | Focal dystonia (HP:0004373) | 1.93016640 |
| 95 | Impaired vibratory sensation (HP:0002495) | 1.91243954 |
| 96 | Type II lissencephaly (HP:0007260) | 1.90863500 |
| 97 | Hypomagnesemia (HP:0002917) | 1.89072485 |
| 98 | Absent septum pellucidum (HP:0001331) | 1.87977819 |
| 99 | Central scotoma (HP:0000603) | 1.87340792 |
| 100 | Abnormality of salivation (HP:0100755) | 1.85974544 |
| 101 | Rigidity (HP:0002063) | 1.85710434 |
| 102 | Gait ataxia (HP:0002066) | 1.84942520 |
| 103 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.83450820 |
| 104 | Clonus (HP:0002169) | 1.82483946 |
| 105 | Clumsiness (HP:0002312) | 1.81057468 |
| 106 | Abnormal drinking behavior (HP:0030082) | 1.79112834 |
| 107 | Polydipsia (HP:0001959) | 1.79112834 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 1.78891938 |
| 109 | Decreased lacrimation (HP:0000633) | 1.78553622 |
| 110 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.77707854 |
| 111 | Anomalous pulmonary venous return (HP:0010772) | 1.77320677 |
| 112 | Abnormality of macular pigmentation (HP:0008002) | 1.77105251 |
| 113 | Thickened helices (HP:0000391) | 1.75926393 |
| 114 | Anosmia (HP:0000458) | 1.74637107 |
| 115 | Deep palmar crease (HP:0006191) | 1.74176888 |
| 116 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.73721079 |
| 117 | Ventricular fibrillation (HP:0001663) | 1.73679912 |
| 118 | Aqueductal stenosis (HP:0002410) | 1.73456163 |
| 119 | Congenital stationary night blindness (HP:0007642) | 1.73455428 |
| 120 | Open mouth (HP:0000194) | 1.73001422 |
| 121 | Specific learning disability (HP:0001328) | 1.72332797 |
| 122 | Termporal pattern (HP:0011008) | 1.70638538 |
| 123 | Insidious onset (HP:0003587) | 1.70638538 |
| 124 | Hyperaldosteronism (HP:0000859) | 1.70490278 |
| 125 | Neuronal loss in central nervous system (HP:0002529) | 1.69446127 |
| 126 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69377609 |
| 127 | Postural tremor (HP:0002174) | 1.69192621 |
| 128 | Spastic tetraplegia (HP:0002510) | 1.68220904 |
| 129 | Protruding tongue (HP:0010808) | 1.68103600 |
| 130 | Epiphyseal dysplasia (HP:0002656) | 1.66818272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.47146838 |
| 2 | CASK | 4.12609305 |
| 3 | EPHA4 | 3.95056644 |
| 4 | TNIK | 3.56371469 |
| 5 | MARK1 | 2.90452078 |
| 6 | FES | 2.73702070 |
| 7 | MAP3K4 | 2.69164504 |
| 8 | TYRO3 | 2.69034869 |
| 9 | MAP3K9 | 2.33831410 |
| 10 | MAP2K7 | 2.20372619 |
| 11 | MINK1 | 2.16709556 |
| 12 | NTRK2 | 2.16195870 |
| 13 | MAPK13 | 2.00561388 |
| 14 | PRPF4B | 1.95543497 |
| 15 | NTRK1 | 1.93283127 |
| 16 | PRKD3 | 1.80332680 |
| 17 | PAK6 | 1.75660848 |
| 18 | FRK | 1.74282797 |
| 19 | DAPK2 | 1.62892481 |
| 20 | MAP3K2 | 1.49991330 |
| 21 | RIPK4 | 1.49797885 |
| 22 | UHMK1 | 1.37488172 |
| 23 | CDK5 | 1.37366526 |
| 24 | KSR2 | 1.37064041 |
| 25 | CAMKK1 | 1.36784656 |
| 26 | MAP2K4 | 1.34920644 |
| 27 | IRAK2 | 1.22890367 |
| 28 | PHKG1 | 1.18950524 |
| 29 | PHKG2 | 1.18950524 |
| 30 | ERBB4 | 1.12482535 |
| 31 | PRKCG | 1.11562553 |
| 32 | NEK6 | 1.10539780 |
| 33 | PNCK | 1.10518816 |
| 34 | CAMK2G | 1.09354339 |
| 35 | KSR1 | 1.07877103 |
| 36 | MAP3K12 | 1.05661066 |
| 37 | WNK3 | 1.05185856 |
| 38 | STK38 | 1.03801990 |
| 39 | PLK2 | 1.01653078 |
| 40 | SGK223 | 1.01332475 |
| 41 | SGK494 | 1.01332475 |
| 42 | CAMK2A | 0.99363091 |
| 43 | DAPK1 | 0.96452663 |
| 44 | SIK2 | 0.95759109 |
| 45 | STK38L | 0.94220898 |
| 46 | OXSR1 | 0.92702165 |
| 47 | BMPR2 | 0.92364555 |
| 48 | PDGFRA | 0.91396010 |
| 49 | INSRR | 0.91319632 |
| 50 | FGFR2 | 0.90897619 |
| 51 | RET | 0.88186832 |
| 52 | PAK3 | 0.87267786 |
| 53 | GRK5 | 0.86825056 |
| 54 | PRKCH | 0.85632295 |
| 55 | PKN1 | 0.85288351 |
| 56 | SGK2 | 0.81411600 |
| 57 | CAMKK2 | 0.80935264 |
| 58 | CAMK2B | 0.80151242 |
| 59 | PDGFRB | 0.79008020 |
| 60 | CAMK4 | 0.74534553 |
| 61 | CAMK1 | 0.74171854 |
| 62 | MARK2 | 0.73823033 |
| 63 | MAPK12 | 0.73650007 |
| 64 | SGK1 | 0.73067409 |
| 65 | STK39 | 0.71357683 |
| 66 | IRAK1 | 0.70926334 |
| 67 | CAMK1G | 0.66895911 |
| 68 | PIK3CA | 0.66423922 |
| 69 | STK11 | 0.64077641 |
| 70 | PRKCE | 0.63936209 |
| 71 | CAMK2D | 0.63667785 |
| 72 | CDC42BPA | 0.62943856 |
| 73 | MAP3K13 | 0.61392645 |
| 74 | PINK1 | 0.60928793 |
| 75 | TAOK1 | 0.60172632 |
| 76 | DDR2 | 0.58378297 |
| 77 | DYRK1A | 0.58033868 |
| 78 | ERBB2 | 0.58009306 |
| 79 | AKT3 | 0.57794758 |
| 80 | CDK14 | 0.57576987 |
| 81 | MAPKAPK5 | 0.57518547 |
| 82 | RIPK1 | 0.56668900 |
| 83 | SGK3 | 0.55678543 |
| 84 | MAP3K1 | 0.55650942 |
| 85 | RPS6KA3 | 0.54873466 |
| 86 | CDK18 | 0.54803438 |
| 87 | CDK19 | 0.54668200 |
| 88 | FYN | 0.54439415 |
| 89 | CDK15 | 0.54073941 |
| 90 | GRK7 | 0.52143507 |
| 91 | ICK | 0.51166249 |
| 92 | TNK2 | 0.50834961 |
| 93 | PDK1 | 0.49861416 |
| 94 | WNK1 | 0.49708274 |
| 95 | CSNK1D | 0.49692579 |
| 96 | DMPK | 0.49350732 |
| 97 | LMTK2 | 0.47327942 |
| 98 | PDPK1 | 0.47190286 |
| 99 | ERBB3 | 0.46254007 |
| 100 | ROCK1 | 0.46251461 |
| 101 | BMX | 0.46117017 |
| 102 | ALK | 0.46109156 |
| 103 | PRKCZ | 0.45755926 |
| 104 | CSNK1G2 | 0.45664594 |
| 105 | CAMK1D | 0.45432839 |
| 106 | CDK11A | 0.45356002 |
| 107 | ROCK2 | 0.43717034 |
| 108 | MAPK10 | 0.42901489 |
| 109 | FGR | 0.42632762 |
| 110 | CSNK1A1 | 0.41525537 |
| 111 | CSNK1A1L | 0.41244408 |
| 112 | PRKCA | 0.40281794 |
| 113 | WNK4 | 0.38876102 |
| 114 | DYRK2 | 0.38570279 |
| 115 | PRKG1 | 0.37564209 |
| 116 | CDK3 | 0.37013186 |
| 117 | CSNK1G3 | 0.36735170 |
| 118 | PRKACA | 0.36685308 |
| 119 | PRKD2 | 0.36399233 |
| 120 | ARAF | 0.36306488 |
| 121 | FER | 0.36286574 |
| 122 | GSK3B | 0.32870944 |
| 123 | PRKCB | 0.32380113 |
| 124 | MAPK4 | 0.31773295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.63442024 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.82373683 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.79779276 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71238199 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70255456 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.61643812 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.49825728 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41940740 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38269673 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30108968 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.22606646 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.10559743 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08270252 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.07108008 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91128962 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81986249 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78222942 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.76844020 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.76266180 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73100338 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.66869577 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58439185 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57169469 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51329779 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50321959 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49628498 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42862907 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38296931 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.37823343 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33800062 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32502712 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31958644 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.31820388 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30706445 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23507286 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.18348226 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15302205 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13146099 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09621767 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08534276 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05984023 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04275576 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04077605 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02583319 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02285411 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.01638731 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00372373 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00011385 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99596101 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99000394 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98243539 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95835670 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87364012 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87344771 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86877110 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.84453524 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84313566 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79598296 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.79545085 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78326875 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77942647 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77908088 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74062761 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73716489 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70507405 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69306284 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68804553 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68191363 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67552890 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65554552 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63620171 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63154187 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61559785 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60505952 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60295430 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58509626 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56859487 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54511642 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54214256 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52067039 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51483369 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.50446924 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49486014 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49430483 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49387529 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48466312 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48313453 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48175997 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46636023 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46019732 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.45381459 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44890557 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44713537 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.44669552 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42556947 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42410348 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41175766 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.41085334 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40250085 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37444786 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36452503 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36317308 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35581482 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35373598 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34439475 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34057830 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33291363 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32736217 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32339767 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32261247 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30654151 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30545733 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30038415 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29912673 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.29883096 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29338816 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28169087 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27958984 |

